These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16181980)

  • 1. The past, present and future of plasmin inhibitor.
    Aoki N
    Thromb Res; 2005; 116(6):455-64. PubMed ID: 16181980
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sodium heparin on activated fibrinolysis in the rat in vivo].
    Badimón L; Villaverde C; Badimón JJ; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):105-8. PubMed ID: 7325697
    [No Abstract]   [Full Text] [Related]  

  • 5. Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom.
    Brazón J; D'Suze G; D'Errico ML; Arocha-Piñango CL; Guerrero B
    Arch Toxicol; 2009 Jul; 83(7):669-78. PubMed ID: 19015833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.
    Pratt HW; Celander DR
    J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor.
    Moroi M; Aoki N
    Thromb Res; 1977 Jun; 10(6):851-6. PubMed ID: 70081
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of epsilon-aminocaproylamino acids on fibrin formation.
    Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W
    Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of thrombin activatable fibrinolysis inhibitor: why is it so important?
    Biscetti F
    Circ Res; 2008 Feb; 102(3):278-9. PubMed ID: 18276924
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent fibrinolysis inhibitor discovered by shape and electrostatic complementarity to the drug tranexamic acid.
    Boström J; Grant JA; Fjellström O; Thelin A; Gustafsson D
    J Med Chem; 2013 Apr; 56(8):3273-80. PubMed ID: 23521080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.
    Hevessy Z; Patthy A; Kárpáti L; Muszbek L
    Thromb Res; 2000 Aug; 99(4):399-406. PubMed ID: 10963790
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.
    Steinmetzer T; Pilgram O; Wenzel BM; Wiedemeyer SJA
    J Med Chem; 2020 Feb; 63(4):1445-1472. PubMed ID: 31658420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrinolytic properties of basic proteins.
    Worowski K; Farbiszewski R; Rzeczycki W
    Experientia; 1972 Apr; 28(4):398-9. PubMed ID: 4260909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor.
    Buelens K; Hillmayer K; Compernolle G; Declerck PJ; Gils A
    Circ Res; 2008 Feb; 102(3):295-301. PubMed ID: 18063813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the antifibrinolytic activity of the esters of 4-aminomethylbenzoic acid (PAMBA)].
    Markwardt F; Neuland P; Klöcking HP
    Pharmazie; 1966 Jun; 21(6):345-8. PubMed ID: 6000982
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N; Morimatsu M; Tanaka K; Horie A
    Thromb Diath Haemorrh; 1970 Oct; 24(1):85-99. PubMed ID: 5483976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.